PRESS RELEASEAB SCIENCE ANNOUNCES A NEW PUBLICATION ON BIORXIV THAT IDENTIFIES AND CHARACTERIZES A NOVEL SMALL SYNTHETIC MOLECULE, AB8939, AS A ...

In October of this year, at just thirty years old, Katie Wygel was diagnosed with Acute Myeloid Leukemia. Since then, she’s ...

The American Society of Hematology/ASH 2025 meeting included AML results from AAML1831, MyeChild01, BIG-1, and PALG-AML1/2016 studies.

The results of the Precision-T Phase 3 study of investigational allogeneic T-cell immunotherapy, Orca-T, were published in the journal Blood.

The most-read coverage of the latest updates in acute myeloid leukemia (AML) for 2025 focused on the evolution of targeted ...

Porter Harmon is now five years cancer-free and got a huge surprise when he went to ring the bell. "I walked in the room and ...

Summary • Curis, Inc. stock jumped 8.6% in after-hours trading to $1.26 after positive clinical trial results for its AML treatment.• 62.5% of patients in the frontline study achieved undetectable ...

Dr. Wen-Han Chang, corresponding author, added, “The work highlights why biomarkers cannot be interpreted in isolation. Tumor context—immune composition, metabolic state, and innate ...

The Albany Med Health System will be implementing temporary visitor restrictions. Also, three people are dead following an alleged murder-suicide in Catskill. These stories, and more, are in your five ...

The FDA approved niraparib and abiraterone acetate (Akeega) in combination with prednisone for treating BRCA2 -mutated ...

The University of Cincinnati's LDDL trains the next generation of researchers and develops new blood cancer treatments.

A new guideline from the American Society of Clinical Oncology (ASCO) offers clear, evidence-based direction for treating ...